{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:47:04Z","timestamp":1791431224100,"version":"4.3.3"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.rmed.2025.108421","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T05:31:34Z","timestamp":1760506294000},"page":"108421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Treatable Traits. Why, What, How?"],"prefix":"10.1016","volume":"249","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3271-3788","authenticated-orcid":false,"given":"Alvar","family":"Agusti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.rmed.2025.108421_bib1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/thoraxjnl-2014-205507","article-title":"The path to personalized medicine in COPD","volume":"69","author":"Agusti","year":"2014","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.rmed.2025.108421_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037483","article-title":"Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype","volume":"7","author":"Agusti","year":"2012","journal-title":"PLoS One"},{"issue":"171","key":"10.1016\/j.rmed.2025.108421_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0143-2023","article-title":"From treatable traits to GETomics in airway disease: moving towards clinical practice","volume":"33","author":"Papi","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2025.108421_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2025.108421_bib5","article-title":"Treatable traits: a new paradigm for 21(st) century management of chronic airway diseases","volume":"53","author":"McDonald","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108421_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106572","article-title":"Moving towards a treatable traits model of care for the management of obstructive airways diseases","volume":"187","author":"Agusti","year":"2021","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108421_bib7","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jaip.2020.09.046","article-title":"Treatable traits that predict health status and treatment response in airway disease","volume":"9","author":"Hiles","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"3","key":"10.1016\/j.rmed.2025.108421_bib8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaip.2023.01.011","article-title":"Treatable traits in airway disease: from theory to practice","volume":"11","author":"Agusti","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"1","key":"10.1016\/j.rmed.2025.108421_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41533-024-00381-y","article-title":"Change is in the air: key questions on the \u2018Treatable Traits\u2019 model for chronic airway diseases in primary care","volume":"34","author":"Agusti","year":"2024","journal-title":"npj Prim. Care Resp. Med."},{"issue":"7","key":"10.1016\/j.rmed.2025.108421_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/resp.14760","article-title":"Treatable traits in pre-COPD: time to extend the treatable traits paradigm beyond established disease","volume":"29","author":"Dharmage","year":"2024","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2025.108421_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2303951","article-title":"Dupilumab for COPD with type 2 inflammation indicated by elevated eosinophils","volume":"389","author":"Bhatt","year":"2023","journal-title":"New Engl. J. Med."},{"issue":"24","key":"10.1016\/j.rmed.2025.108421_bib13","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJMoa2401304","article-title":"Dupilumab for COPD with blood eosinophil evidence of type 2 inflammation","volume":"390","author":"Bhatt","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108421_bib14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S2213-2600(24)00409-0","article-title":"Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials","volume":"13","author":"Bhatt","year":"2025","journal-title":"Lancet Respir. Med."},{"issue":"17","key":"10.1016\/j.rmed.2025.108421_bib15","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1056\/NEJMoa2413181","article-title":"Mepolizumab to prevent exacerbations of COPD with an eosinophilic phenotype","volume":"392","author":"Sciurba","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.rmed.2025.108421_bib16","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMe2503292","article-title":"Mepolizumab in COPD \u2014 if at first you don't succeed","volume":"392","author":"Dransfield","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108421_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01269-2018","article-title":"Treatable traits in bronchiectasis","volume":"52","author":"Boaventura","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"9979","key":"10.1016\/j.rmed.2025.108421_bib18","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(15)60693-6","article-title":"Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management","volume":"385","author":"Woodruff","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.rmed.2025.108421_bib19","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/resp.14325","article-title":"Treatable traits in the NOVELTY study","volume":"27","author":"Agust\u00ed","year":"2022","journal-title":"Respirology"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125004846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125004846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:08:39Z","timestamp":1763690919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125004846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":18,"alternative-id":["S0954611125004846"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108421","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatable Traits. Why, What, How?","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108421"}}